Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Yuen KCJ"" wg kryterium: Autor


Tytuł:
Spotlight on Lonapegsomatropin Once-Weekly Injection and Its Potential in the Treatment of Growth Hormone Deficiency in Pediatric Patients
Autorzy:
Miller BS
Yuen KCJ
Pokaż więcej
Temat:
growth
long-acting growth hormone
igf-1
growth hormone deficiency
pediatric
adult
Therapeutics. Pharmacology
RM1-950
Źródło:
Drug Design, Development and Therapy, Vol Volume 16, Pp 2055-2066 (2022)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/spotlight-on-lonapegsomatropin-once-weekly-injection-and-its-potential-peer-reviewed-fulltext-article-DDDT; https://doaj.org/toc/1177-8881
Dostęp URL:
https://doaj.org/article/fddafc97de14438c9b93bfc4f85d6e8a  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Medical Costs Associated with High/Moderate/Low Likelihood of Adult Growth Hormone Deficiency: A Healthcare Claims Database Analysis.
Autorzy:
Yuen KCJ; Barrow Pituitary Center, Barrow Neurological Institute and St. Joseph's Hospital and Medical Center, University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, AZ, USA.
Blevins LS; Department of Neurosurgery, University of California, San Francisco, CA, USA.
Clemmons DR; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Faurby M; Global Evidence, Pricing and Access, Novo Nordisk A/S, Søborg, Denmark.
Hoffman AR; Department of Medicine, Stanford University, Stanford, CA, USA.
Kelepouris N; Department of Medical Affairs BioPharm, CMR, Novo Nordisk Inc., Plainsboro, NJ, USA.
Kerr JM; Department of Endocrinology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.
Tarp JM; Global Evidence, Pricing and Access, Novo Nordisk A/S, Søborg, Denmark.
Fleseriu M; Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health and Science University, Portland, OR, USA.
Pokaż więcej
Źródło:
ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2024 Mar 08; Vol. 16, pp. 133-147. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan.
Autorzy:
Miller BS; Division of Pediatric Endocrinology, University of Minnesota Medical School, MHealth Fairview Masonic Children's Hospital, Minneapolis, MN, USA.
Blair J; Department of Paediatric Endocrinology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
Horikawa R; Division of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo, Japan.
Linglart A; Department of Endocrinology and Diabetes for Children, Hospital Bicêtr Paris Saclay, AP-HP, Le Kremlin-Bicêtre, France.; Unité 1185, INSERM, Paris, France.; Reference Center for Rare Pituitary Disorders, Hospital Bicêtre Paris Saclay, AP-HP, Le Kremlin-Bicêtre, France.; Platform of Expertise for Rare Diseases, OSCAR Network, Hospital Bicêtre Paris Saclay, AP-HP, Le Kremlin-Bicêtre, France.
Yuen KCJ; Departments of Neuroendocrinology and Neurosurgery, Barrow Neurological Institute, University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, AZ, USA.
Pokaż więcej
Źródło:
Drug design, development and therapy [Drug Des Devel Ther] 2024 Feb 03; Vol. 18, pp. 291-306. Date of Electronic Publication: 2024 Feb 03 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Human Growth Hormone*/therapeutic use
Dwarfism, Pituitary*/drug therapy
Histidine*
Mannitol*
Phenol*
Adult ; Humans ; Child ; United States ; Growth Hormone/pharmacokinetics ; Growth Hormone/therapeutic use ; Treatment Outcome ; Insulin-Like Growth Factor I
Czasopismo naukowe
Tytuł:
Insights from an advisory board: Facilitating transition of care into adulthood in brain cancer survivors with acquired pediatric growth hormone deficiency.
Autorzy:
Alter C; Children's Hospital of Philadelphia, Philadelphia, PA, USA. Electronic address: .
Boguszewski M; Federal University of Paraná, Curitiba, Brazil. Electronic address: .
Clemmons D; University of North Carolina School of Medicine, Chapel Hill, NC, USA. Electronic address: .
Dobri GA; Weill Cornell Medicine, New York, NY, USA. Electronic address: .
Geffner ME; Keck School of Medicine, University of Southern California, Children's Hospital Los Angeles, Los Angeles, CA, USA. Electronic address: .
Kelepouris N; Novo Nordisk Inc., Plainsboro, NJ, USA. Electronic address: .
Miller BS; University of Minnesota Medical School, M Health Fairview Masonic Children's Hospital, Minneapolis, MN, USA. Electronic address: .
Oh R; Novo Nordisk Inc., Plainsboro, NJ, USA. Electronic address: .
Shea H; Endocrine Associates of Dallas, Dallas, TX, USA. Electronic address: .
Yuen KCJ; Barrow Pituitary Center, Barrow Neurological Institute, University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, AZ, USA. Electronic address: kevin.yuen@commonspirit.org.
Pokaż więcej
Źródło:
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society [Growth Horm IGF Res] 2024 Feb; Vol. 74, pp. 101573. Date of Electronic Publication: 2024 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer Survivors*
Human Growth Hormone*
Dwarfism, Pituitary*
Hypopituitarism*
Brain Neoplasms*/complications
Brain Neoplasms*/therapy
Adult ; Humans ; Child ; Patient Transfer ; Growth Hormone/therapeutic use ; Brain
Czasopismo naukowe
Tytuł:
Coverage of education and training of traumatic brain injury-induced growth hormone deficiency in US residency and fellowship programs: a cross-sectional study.
Autorzy:
Cárdenas J; Rockefeller Neuroscience Institute, West Virginia University, 33 Medical Center Dr, Morgantown, WV, 26506, USA.
Kelepouris N; Novo Nordisk Inc, 800 Scudders Mill Rd, Plainsboro, NJ, 08536, USA.
Adiga R; Novo Nordisk Inc, 800 Scudders Mill Rd, Plainsboro, NJ, 08536, USA.
Yuen KCJ; Barrow Neurological Institute, 240 W Thomas Rd, Suite 404, Phoenix, AZ, 85013, USA. kevin.yuen@commonspirit.org.
Pokaż więcej
Źródło:
BMC medical education [BMC Med Educ] 2024 Jan 10; Vol. 24 (1), pp. 53. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
Internship and Residency*
Hypopituitarism*
Brain Injuries, Traumatic*/complications
Brain Injuries, Traumatic*/therapy
Humans ; Cross-Sectional Studies ; Fellowships and Scholarships ; Growth Hormone
Czasopismo naukowe
Tytuł:
Is there a role for growth hormone replacement in adults to control acute and post-acute COVID-19?
Autorzy:
Venugopal N; John Sealy School of Medicine, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA. Electronic address: .
Armstrong PA; John Sealy School of Medicine, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA. Electronic address: .
Wright TJ; Department of Internal Medicine, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA. Electronic address: .
Randolph KM; Department of Internal Medicine, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA. Electronic address: .
Batson RD; Neurevolution Medicine, Friday Harbor, WA 98004, USA. Electronic address: .
Yuen KCJ; Department of Neuroendocrinology, Barrow Pituitary Center and Barrow Neuroendocrinology Clinic, St. Joseph's Hospital and Medical Center, Phoenix, AZ 85013, USA. Electronic address: kevin.yuen@commonspirit.org.
Masel B; Department of Neurology, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA; Centre for Neuro Skills, Bakersfield, CA 93313, USA. Electronic address: .
Sheffield-Moore M; Department of Internal Medicine, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA. Electronic address: .
Pyles RB; Department of Pediatrics, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA. Electronic address: .
Urban RJ; Department of Internal Medicine, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, USA. Electronic address: .
Pokaż więcej
Źródło:
Best practice & research. Clinical endocrinology & metabolism [Best Pract Res Clin Endocrinol Metab] 2023 Dec; Vol. 37 (6), pp. 101842. Date of Electronic Publication: 2023 Nov 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*
Human Growth Hormone*
Adult ; Humans ; Growth Hormone/therapeutic use ; SARS-CoV-2 ; Post-Acute COVID-19 Syndrome ; Disease Progression
Czasopismo naukowe
Tytuł:
Traumatic brain injury, abnormal growth hormone secretion, and gut dysbiosis.
Autorzy:
Armstrong PA; John Sealy School of Medicine, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, United States. Electronic address: .
Venugopal N; John Sealy School of Medicine, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, United States. Electronic address: .
Wright TJ; Department of Internal Medicine, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, United States. Electronic address: .
Randolph KM; Department of Internal Medicine, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, United States. Electronic address: .
Batson RD; Neurevolution Medicine, Friday Harbor, WA 98004, United States. Electronic address: .
Yuen KCJ; Department of Neuroendocrinology, Barrow Pituitary Center and Barrow Neuroendocrinology Clinic, St. Joseph's Hospital and Medical Center, Phoenix, AZ 85013 United States. Electronic address: kevin.yuen@commonspirit.org.
Masel BE; Department of Neurology, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, United States; Centre for Neuro Skills, Bakersfield, CA 93313, United States. Electronic address: .
Sheffield-Moore M; Department of Internal Medicine, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, United States. Electronic address: .
Urban RJ; Department of Internal Medicine, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, United States. Electronic address: .
Pyles RB; Department of Pediatrics, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555, United States. Electronic address: .
Pokaż więcej
Źródło:
Best practice & research. Clinical endocrinology & metabolism [Best Pract Res Clin Endocrinol Metab] 2023 Dec; Vol. 37 (6), pp. 101841. Date of Electronic Publication: 2023 Nov 19.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Brain Injuries, Traumatic*/complications
Brain Injuries*/complications
Human Growth Hormone*/therapeutic use
Humans ; Dysbiosis/complications ; Growth Hormone/therapeutic use ; Growth Hormone/metabolism ; Fatigue/complications ; Insulin-Like Growth Factor I/metabolism
Czasopismo naukowe
Tytuł:
Best Practice and Research Clinical Endocrinology and Metabolism focusing on Growth Hormone Deficiency in Adults - New Perspectives.
Autorzy:
Yuen KCJ; Department of Neuroendocrinology and Neurosurgery, Barrow Pituitary Center, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, Unites States; University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, AZ, United States. Electronic address: kevin.yuen@dignityhealth.org.
Pokaż więcej
Źródło:
Best practice & research. Clinical endocrinology & metabolism [Best Pract Res Clin Endocrinol Metab] 2023 Dec; Vol. 37 (6), pp. 101840. Date of Electronic Publication: 2023 Nov 21.
Typ publikacji:
Editorial
MeSH Terms:
Endocrinology*
Dwarfism, Pituitary*
Hypopituitarism*
Human Growth Hormone*
Adult ; Humans ; Growth Hormone
Opinia redakcyjna
Tytuł:
Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis.
Autorzy:
Yuen KCJ; Departments of Neuroendocrinology and Neurosurgery, Barrow Neurological Institute, University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, Arizona, United States.
Johannsson G; Department of Endocrinology, Sahlgrenska University Hospital and Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Ho KKY; The Garvan Institute of Medical Research and the Faculty of Medicine, University of New South Wales, Sydney, Australia.
Miller BS; Pediatric Endocrinology, University of Minnesota Medical School, M Health Fairview Masonic Children's Hospital, Minneapolis, Minnesota, United States.
Bergada I; Centro de Investigaciones Endocrinológicas 'Dr César Bergadá' (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina.
Rogol AD; Pediatric Diabetes and Endocrinology, University of Virginia, Charlottesville, Virginia, United States.
Pokaż więcej
Źródło:
Endocrine connections [Endocr Connect] 2023 Jun 12; Vol. 12 (7). Date of Electronic Publication: 2023 Jun 12 (Print Publication: 2023).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators.
Autorzy:
Mallick S; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, Arizona.
Chakrabarti J; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, Arizona.
Eschbacher J; Department of Neuropathology, Barrow Neurological Institute, Phoenix, Arizona.
Moraitis AG; Corcept Therapeutics, Inc, Menlo Park, California.
Greenstein AE; Corcept Therapeutics, Inc, Menlo Park, California.
Churko J; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, Arizona.
Pond KW; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, Arizona.
Livolsi A; MilliporeSigma - Life Science, Rockville, Maryland.
Thorne CA; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, Arizona.
Little AS; Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona.
Yuen KCJ; Department of Neuroendocrinology, Barrow Neurological Institute, Phoenix, Arizona.
Zavros Y; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, Arizona. Electronic address: .
Pokaż więcej
Źródło:
Translational research : the journal of laboratory and clinical medicine [Transl Res] 2023 Jun; Vol. 256, pp. 56-72. Date of Electronic Publication: 2023 Jan 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Pituitary ACTH Hypersecretion*/drug therapy
Pituitary ACTH Hypersecretion*/metabolism
Pituitary ACTH Hypersecretion*/pathology
Pituitary Neoplasms*/drug therapy
Pituitary Neoplasms*/metabolism
Pituitary Neoplasms*/pathology
Humans ; Corticotrophs/metabolism ; Corticotrophs/pathology ; Receptors, Glucocorticoid/genetics ; Receptors, Glucocorticoid/metabolism ; Receptors, Glucocorticoid/therapeutic use ; Mifepristone/pharmacology ; Mifepristone/metabolism ; Mifepristone/therapeutic use ; Hedgehog Proteins ; Adrenocorticotropic Hormone/pharmacology ; Adrenocorticotropic Hormone/metabolism ; Adrenocorticotropic Hormone/therapeutic use
Czasopismo naukowe
Tytuł:
Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency.
Autorzy:
Takahashi Y; Department of Diabetes and Endocrinology, Nara Medical University, 840 Shijo-Cho, Kashihara, Nara, 634-8522, Japan. .
Biller BMK; Neuroendocrine & Pituitary Tumor Clinical Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Fukuoka H; Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe, Japan.
Ho KKY; Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, Australia.; UNSW Sydney, Sydney, Australia.
Rasmussen MH; Global Development, Novo Nordisk A/S, Søborg, Denmark.
Nedjatian N; Global Medical Affairs-Rare Endocrine Disorders, Novo Nordisk Health Care AG, Zurich, Switzerland.
Sværke C; Global Development, Novo Nordisk A/S, Søborg, Denmark.
Yuen KCJ; Barrow Pituitary Center, Barrow Neurological Institute and St. Joseph's Hospital and Medical Center, University of Arizona College of Medicine, Phoenix, AZ, USA.; Creighton School of Medicine, Phoenix, AZ, USA.
Johannsson G; Institute of Medicine, Sahlgrenska Academy, University of Göteborg, Göteborg, Sweden.; Department of Endocrinology, Sahlgrenska University Hospital, Göteborg, Sweden.
Pokaż więcej
Źródło:
Pituitary [Pituitary] 2023 Feb; Vol. 26 (1), pp. 57-72. Date of Electronic Publication: 2022 Nov 15.
Typ publikacji:
Journal Article
MeSH Terms:
Human Growth Hormone*/therapeutic use
Dwarfism, Pituitary*/drug therapy
Humans ; Adult ; Glycated Hemoglobin ; Growth Hormone/therapeutic use ; Insulin ; Glucose/therapeutic use
Czasopismo naukowe
Tytuł:
Iatrogenic immunodeficiency-associated lymphoproliferative disorders of the central nervous system: a treatment paradox.
Autorzy:
Tadipatri R; Specialty Clinic, Flagstaff Medical Center, Flagstaff, Arizona, USA.
Ekhator C; College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, New York, USA.
Narayan R; Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA.
Azadi A; Neuroscience Institute, HonorHealth, Scottsdale, Arizona, USA.
Yuen KCJ; Department of Neuroendocrinology, Barrow Neurological Institute, Phoenix, Arizona, USA.
Grewal J; Neurological Surgery, P.C., Rockville Center, New York, USA.; Mount Sinai South Nassau Hospital, Oceanside, New York, USA.
Fonkem E; Department of Neurosurgery, Baylor Scott and White Health, Temple, Texas, USA.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2022 Dec 31; Vol. 10 (2), pp. 169-175. Date of Electronic Publication: 2022 Dec 31 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Development of Human Pituitary Neuroendocrine Tumor Organoids to Facilitate Effective Targeted Treatments of Cushing's Disease.
Autorzy:
Chakrabarti J; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
Pandey R; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85721, USA.; Center for Biomedical Informatics and Biostatistics, University of Arizona Health Sciences, Tucson, AZ 85721, USA.
Churko JM; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
Eschbacher J; Department of Neuropathology, Barrow Neurological Institute, Phoenix, AZ 85013, USA.
Mallick S; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
Chen Y; University of Arizona Cancer Center Bioinformatics Core, Tucson, AZ 85721, USA.
Hermes B; Department of Neuropathology, Barrow Neurological Institute, Phoenix, AZ 85013, USA.
Mallick P; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
Stansfield BN; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
Pond KW; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
Thorne CA; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
Yuen KCJ; Department of Neuroendocrinology, Barrow Neurological Institute, Phoenix, AZ 85013, USA.
Little AS; Department of Neurosurgery, Barrow Neurological Institute, Phoenix, AZ 85013, USA.
Zavros Y; Department of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85721, USA.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Oct 23; Vol. 11 (21). Date of Electronic Publication: 2022 Oct 23.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Pituitary ACTH Hypersecretion*/drug therapy
Pituitary ACTH Hypersecretion*/surgery
Pituitary Neoplasms*
Neuroendocrine Tumors*/drug therapy
Humans ; Organoids ; Hydrocortisone ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
A consensus on optimization of care in patients with growth hormone deficiency and mild traumatic brain injury.
Autorzy:
Yuen KCJ; Barrow Pituitary Center, Barrow Neurological Institute, University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, AZ, USA.
Masel B; Department of Neurology, University of Texas Medical Branch, Galveston, TX, USA.
Jaffee MS; Department of Neurology, University of Florida, Gainesville, FL, USA.
O'Shanick G; Center for Neurorehabilitation Services, Richmond, VA, USA.
Wexler TL; Rusk Rehabilitation, NYU Langone Health, New York, NY, USA; University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Reifschneider K; Division of Endocrinology, Children's Hospital of The King's Daughters, Norfolk, VA, USA.
Urban RJ; Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, USA.
Hoang S; Novo Nordisk Inc., Plainsboro, NJ, USA.
Kelepouris N; Novo Nordisk Inc., Plainsboro, NJ, USA. Electronic address: .
Hoffman AR; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Pokaż więcej
Źródło:
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society [Growth Horm IGF Res] 2022 Oct; Vol. 66, pp. 101495. Date of Electronic Publication: 2022 Jul 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Brain Concussion*/complications
Brain Concussion*/diagnosis
Brain Concussion*/therapy
Brain Injuries*/metabolism
Human Growth Hormone*
Hypopituitarism*/diagnosis
Hypopituitarism*/etiology
Hypopituitarism*/therapy
Dwarfism, Pituitary*
Adult ; Humans ; Child ; Consensus ; Growth Hormone
Czasopismo naukowe
Tytuł:
Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database.
Autorzy:
Yuen KCJ; Barrow Pituitary Center, Barrow Neurological Institute and St. Joseph's Hospital and Medical Center, University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, AZ, USA.
Birkegard AC; Novo Nordisk A/S, Søborg, Denmark.
Blevins LS; Department of Neurosurgery, University of California, San Francisco, CA, USA.
Clemmons DR; Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Hoffman AR; Department of Medicine, Stanford University, Stanford, CA, USA.
Kelepouris N; Novo Nordisk Inc., Plainsboro, NJ, USA.
Kerr JM; Department of Endocrinology, University of Colorado Health Sciences Center, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA.
Tarp JM; Novo Nordisk A/S, Søborg, Denmark.
Fleseriu M; Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health and Science University, Portland, OR, USA.
Pokaż więcej
Źródło:
International journal of endocrinology [Int J Endocrinol] 2022 Jun 18; Vol. 2022, pp. 7853786. Date of Electronic Publication: 2022 Jun 18 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Quality of life after long-term biochemical control of acromegaly.
Autorzy:
Kimball A; Neuroendocrine Unit, Massachusetts General Hospital, 55 Fruit Street, Bulfinch 457, Boston, MA, 02114, USA. .; Harvard Medical School, Boston, MA, USA. .
Dichtel LE; Neuroendocrine Unit, Massachusetts General Hospital, 55 Fruit Street, Bulfinch 457, Boston, MA, 02114, USA.; Harvard Medical School, Boston, MA, USA.
Yuen KCJ; Swedish Pituitary Center, Swedish Neuroscience Institute, Seattle, WA, USA.; Barrow Pituitary Center, Barrow Neurological Institute, University of Arizona School of Medicine and Creighton School of Medicine, Phoenix, AZ, USA.
Woodmansee WW; Harvard Medical School, Boston, MA, USA.; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA, USA.; Division of Endocrinology, Diabetes and Metabolism, University of Florida, Gainesville, FL, USA.
Haines MS; Neuroendocrine Unit, Massachusetts General Hospital, 55 Fruit Street, Bulfinch 457, Boston, MA, 02114, USA.; Harvard Medical School, Boston, MA, USA.
Nachtigall LB; Neuroendocrine Unit, Massachusetts General Hospital, 55 Fruit Street, Bulfinch 457, Boston, MA, 02114, USA.; Harvard Medical School, Boston, MA, USA.
Swearingen B; Harvard Medical School, Boston, MA, USA.; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA.
Jones P; Harvard Medical School, Boston, MA, USA.; Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, USA.
Tritos NA; Neuroendocrine Unit, Massachusetts General Hospital, 55 Fruit Street, Bulfinch 457, Boston, MA, 02114, USA.; Harvard Medical School, Boston, MA, USA.
Sharpless JL; Department of Endocrinology, University of North Carolina, Chapel Hill, NC, USA.; National Institutes of Health, Bethesda, MD, USA.
Kaiser UB; Harvard Medical School, Boston, MA, USA.; Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA, USA.
Gerweck A; Neuroendocrine Unit, Massachusetts General Hospital, 55 Fruit Street, Bulfinch 457, Boston, MA, 02114, USA.
Miller KK; Neuroendocrine Unit, Massachusetts General Hospital, 55 Fruit Street, Bulfinch 457, Boston, MA, 02114, USA.; Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło:
Pituitary [Pituitary] 2022 Jun; Vol. 25 (3), pp. 531-539. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji:
Journal Article
MeSH Terms:
Acromegaly*/drug therapy
Adult ; Cross-Sectional Studies ; Growth Hormone/therapeutic use ; Humans ; Quality of Life ; Surveys and Questionnaires
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies